Begin main content

Search

We found 6820 result(s)

An assessment of oseltamivir for the treatment of suspected influenza

Last Updated: April 2, 2002
Result type: Reports

Cite as: Husereau DR, Brady B, McGeer A. An assessment of oseltamivir for the treatment of suspected influenza. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002. Technology overview no 7. The Issue Annually, influenza causes significant morbidity and mortality. It is difficult to diagnose true influenza with...

Activated protein C for severe sepsis

Last Updated: April 1, 2002
Result type: Reports

Severe sepsis is a systemic inflammatory response to infection involving organ dysfunction. Severe sepsis is a common cause of death and is associated with a 20%1 to 56% mortality rate. Drotrecogin alpha (activated) is a recombinant human activated protein C (rhAPC) approved in the U.S. for the reduction of mortality in adult patients wi...

Radiofrequency catheter ablation for cardiac arrhythmias: A clinical and economic review

Last Updated: April 1, 2002
Result type: Reports

Cite as: Noorani HZ, Yee R, Marshall D, Connolly S, Nichol G, O'Brien B. Radiofrequency catheter ablation for cardiac arrhythmias: a clinical and economic review. Ottawa: Canadian Coordinating Office for Health Technology Assessment. 2002. Technology report no 25. The Issue Catheter ablation is a procedure intended for the treatment of patient...

Computer-enhanced surgical systems (“robotic surgery”)

Last Updated: March 27, 2002
Result type: Reports

Computer-linked surgical systems allow surgeons to perform procedures without coming into contact with the patient. Indications for these robotic surgery systems are expanding. This technology offers potential advantages through enabling more precise surgery, which may lead to shorter patient recovery times, fewer complications and improved p...

Infliximab for the treatment of Crohn’s disease: A systematic review and cost-utility analysis

Last Updated: March 25, 2002
Result type: Reports

Cite as: Marshall J, Blackhouse G, Goeree R, Brazier N, Irvine E, Faulkner L, Dipchand C, O'Brien B. Infliximab for the Treatment of Crohn's Disease: A Systematic Review and Cost-Utility Analysis. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002. Technology report no 24. The Issue Crohn's disease (CD) is a c...

Extracorporeal immunoadsorption treatment for rheumatoid arthritis

Last Updated: March 15, 2002
Result type: Reports

Immunoadsorption treatment is a non-drug therapy for rheumatoid arthritis. The treatment is based on filtering the patient's plasma through a column containing staphylococcal protein A. The treatment is effective in alleviating the symptoms of severe rheumatoid arthritis in some patients. Data on long-term outcomes are not available.

The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis

Last Updated: February 22, 2002
Result type: Reports

Cite as: Maetzel A, Krahn M, Naglie G. The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002. Technology report no 23. The Issue Nonsteroidal anti-inflammatory drugs (NSAIDs) are core therapeutics in the man...